<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">ophthalmology</journal-id><journal-title-group><journal-title xml:lang="ru">Офтальмология</journal-title><trans-title-group xml:lang="en"><trans-title>Ophthalmology in Russia</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1816-5095</issn><issn pub-type="epub">2500-0845</issn><publisher><publisher-name>Ophthalmology</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.18008/1816-5095-2023-1-143-150</article-id><article-id custom-type="elpub" pub-id-type="custom">ophthalmology-2054</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КЛИНИЧЕСКИЕ И ЭКСПЕРИМЕНТАЛЬНЫЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CLINICAL &amp; EXPERIMENTAL RESEARCH</subject></subj-group></article-categories><title-group><article-title>Мультимодальная визуализация «молчащих» хориоидальных неоваскулярных мембран: статус пигментного эпителия сетчатки</article-title><trans-title-group xml:lang="en"><trans-title>Multimodal Imaging of Quiescent Choroidal Neovascularization: Status of Retinal Pigment Epithelium</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5274-6993</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Куликов</surname><given-names>А. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Kulikov</surname><given-names>A. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Куликов Алексей Николаевич - доктор медицинских наук, профессор, начальник кафедры офтальмологии имени профессора В.В. Волкова</p><p>ул. Боткинская, 21, г. Санкт‑Петербург, 194044, Российская Федерация</p></bio><bio xml:lang="en"><p>Kulikov Alexey N. - MD, Professor, head of the Ophthalmology department </p><p> Botkinskaya str., 21, Saint Petersburg, 194044, Russian Federation </p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6598-3982</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мальцев</surname><given-names>Д. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Maltsev</surname><given-names>D. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Мальцев Дмитрий Сергеевич - доктор медицинских наук, заведующий отделением лазерной хирургии клиники офтальмологии</p><p>ул. Боткинская, 21, Санкт‑Петербург, 194044, Российская Федерация</p></bio><bio xml:lang="en"><p>Maltsev Dmitrii S. - MD, head of Medical retina division of Ophthalmology department </p><p> Botkinskaya str., 21, Saint Petersburg, 194044, Russian Federation </p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5697-5630</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Перминова</surname><given-names>С. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Perminova</surname><given-names>S. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Перминова Софья Михайловна - врач‑офтальмолог клиники офтальмологии</p><p>ул. Боткинская, 21, Санкт‑Петербург, 194044, Российская Федерация</p></bio><bio xml:lang="en"><p>Perminova Sofya M. - ophthalmologist of the Ophthalmology department </p><p> Botkinskaya str., 21, Saint Petersburg, 194044, Russian Federation </p></bio><email xlink:type="simple">perminova_sofya@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2948-7815</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Васильев</surname><given-names>А. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Vasilev</surname><given-names>A. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Васильев Александр Сергеевич - врач‑офтальмолог клиники офтальмологии</p><p>ул. Боткинская, 21, Санкт‑Петербург, 194044, Российская Федерация</p></bio><bio xml:lang="en"><p>Vasilev Aleksandr S. - ophthalmologist of the Ophthalmology department </p><p> Botkinskaya str., 21, Saint Petersburg, 194044, Russian Federation </p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБВОУ ВО «Военно-медицинская академия им. С.М. Кирова» Министерства обороны Российской Федерации</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Military Medical Academy named after S.M. Kirov</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>06</day><month>04</month><year>2023</year></pub-date><volume>20</volume><issue>1</issue><fpage>143</fpage><lpage>150</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Куликов А.Н., Мальцев Д.С., Перминова С.М., Васильев А.С., 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="ru">Куликов А.Н., Мальцев Д.С., Перминова С.М., Васильев А.С.</copyright-holder><copyright-holder xml:lang="en">Kulikov A.N., Maltsev D.S., Perminova S.M., Vasilev A.S.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.ophthalmojournal.com/opht/article/view/2054">https://www.ophthalmojournal.com/opht/article/view/2054</self-uri><abstract><sec><title>Цель</title><p>Цель: изучить статус пигментного эпителия сетчатки (ПЭС) над областью «молчащей» хориоидальной неоваскуляризации (ХНВ) в сравнении с активной ХНВ при неоваскулярной возрастной макулярной дегенерации (нВМД).</p></sec><sec><title>Пациенты и методы</title><p>Пациенты и методы: в исследование включены 17 пациентов с «молчащей» ХНВ (6 мужчин и 11 женщин, средний возраст 74,9 ± 10,0 года) и 28 пациентов с активной ХНВ (8 мужчин и 20 женщин, средний возраст 69,3 ± 6,8 года). Все участники прошли стандартное офтальмологическое обследование, включая спектральную оптическую когерентную томографию (ОКТ), темнопольную сканирующую лазерную офтальмоскопию (ТП-СЛО) и аутофлюоресценцию. С помощью ImageJ оценивали яркость изображения в проекции ХНВ. Сосудистая плотность мембраны была оценена с помощью ОКТ ангиографии.</p></sec><sec><title>Результаты</title><p>Результаты. Сосудистая плотность «молчащих» ХНВ была статистически значимо выше, чем активной ХНВ, с медианным значением 64,5 % (95 % доверительный интервал (ДИ) 53,4–79,0 %) и 55,3 % (95 % ДИ 52,2–60,0 %) (p = 0,05). Яркость изображения в области «молчащей» мембраны была существенно ниже по сравнению с активной ХНВ как по данным ОКТ трансиллюминации (p = 0,004), так и по данным ТП-СЛО (p = 0,0015). Не было выявлено различий в показателях аутофлюоресценции между активной и «молчащей» ХНВ (p = 0,44).</p></sec><sec><title>Заключение</title><p>Заключение. Мультимодальная визуализация указывает на существенные потери целостности ПЭС над активными мембранами, чему соответствует их более низкая сосудистая плотность по данным ОКТ ангиографии.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Purpose</title><p>Purpose: to study the status of retinal pigment epithelium (RPE) over the area of quiescent choroidal neovascularization (CNV) in comparison with active CNV in neovascular age-related macular degeneration (nAMD).</p></sec><sec><title>Patients and methods</title><p>Patients and methods: This study included 17 patients with quiescent CNV (6 males and 11 females, mean age 74.9 ± 10.0 years) and 28 patients with active CNV (8 males and 20 females, average age 69.3 ± 6.8 years). All participants received a standard ophthalmological examination, including spectral optical coherence tomography (OCT), dark-field scanning laser ophthalmoscopy (DF-SLO) and autofluorescence. Using ImageJ, the brightness of the image in the projection of the CNV was evaluated. The vascular density of the membrane was assessed using OCT angiography.</p></sec><sec><title>Results</title><p>Results: The vascular density of quiescent CNV was statistically significantly higher than that of active CNV with a median value of 64.5 % (95 % confidence interval (CI) 53.4–79.0 %) and 55.3 % (95 % CI 52.2–60.0 %) (p = 0.05). Image brightness in the silent membrane region was significantly lower by compared with active CNV, both according to OCT transillumination data (p = 0.004) and according to DF-SLO data (p = 0.0015). There were no differences in autofluorescence indices between active and quiescent CNV (p = 0.44).</p></sec><sec><title>Conclusion</title><p>Conclusion: Multimodal imaging indicates significant loss of integrity of RPE over active CNV, which corresponds to their lower vascular density according to OCT angiography.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>пигментный эпителий сетчатки</kwd><kwd>неоваскулярная возрастная макулярная дегенерация</kwd><kwd>хориоидальная неоваскуляризация</kwd><kwd>оптическая когерентная томография</kwd><kwd>аутофлюоресценция</kwd><kwd>сканирующая лазерная офтальмоскопия</kwd><kwd>оптическая когерентная томография ангиография</kwd></kwd-group><kwd-group xml:lang="en"><kwd>retinal pigment epithelium</kwd><kwd>neovascular age-related macular degeneration</kwd><kwd>choroidal neovascularization</kwd><kwd>optical coherence tomography</kwd><kwd>autofluorescence</kwd><kwd>scanning laser ophthalmoscopy</kwd><kwd>optical coherence tomography angiography</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Wong WL, Su X, Li X. Global prevalence of age related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health. 2014;2(2):e106–116. DOI: 10.1016/S2214-109X(13)70145-1</mixed-citation><mixed-citation xml:lang="en">Wong WL, Su X, Li X. Global prevalence of age related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health. 2014;2(2):e106–116. DOI: 10.1016/S2214-109X(13)70145-1</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Flores R, Carneiro Â, Vieira M, Tenreiro S, Seabra MC. Age Related Macular Degeneration: Pathophysiology, Management, and Future Perspectives. Ophthalmologica. 2021;244(6):495–511. DOI: 10.1159/000517520</mixed-citation><mixed-citation xml:lang="en">Flores R, Carneiro Â, Vieira M, Tenreiro S, Seabra MC. Age Related Macular Degeneration: Pathophysiology, Management, and Future Perspectives. Ophthalmologica. 2021;244(6):495–511. DOI: 10.1159/000517520</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Flaxel CJ, Adelman RA, Bailey ST. Age-Related Macular Degeneration Preferred Practice Pattern®. Ophthalmology. 2020;127(1):P1–P65. DOI: 10.1016/j.oph-tha.2019.09.024</mixed-citation><mixed-citation xml:lang="en">Flaxel CJ, Adelman RA, Bailey ST. Age-Related Macular Degeneration Preferred Practice Pattern®. Ophthalmology. 2020;127(1):P1–P65. DOI: 10.1016/j.oph-tha.2019.09.024</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Querques G, Srour M, Massamba N. Functional characterization and multimodal imaging of treatment naive “quiescent” choroidal neovascularization. Invest Ophthalmol Vis Sci. 2013;54(10):6886–6892. DOI: 10.1167/iovs.13-11665</mixed-citation><mixed-citation xml:lang="en">Querques G, Srour M, Massamba N. Functional characterization and multimodal imaging of treatment naive “quiescent” choroidal neovascularization. Invest Ophthalmol Vis Sci. 2013;54(10):6886–6892. DOI: 10.1167/iovs.13-11665</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Carnevali A, Sacconi R, Querques L. Natural History of Treatment-Naïve Quiescent Choroidal Neovascularization in Age Related Macular Degeneration Using OCT Angiography. Ophthalmol Retina. 2018;2(9):922–930. DOI: 10.1016/j.oret.2018.02.002</mixed-citation><mixed-citation xml:lang="en">Carnevali A, Sacconi R, Querques L. Natural History of Treatment-Naïve Quiescent Choroidal Neovascularization in Age Related Macular Degeneration Using OCT Angiography. Ophthalmol Retina. 2018;2(9):922–930. DOI: 10.1016/j.oret.2018.02.002</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Maltsev DS, Kulikov AN, Burnasheva MA, Chhablani J. En face optical coherence tomography transillumination for evaluation of retinal pigment epithelium alteration in central serous chorioretinopathy: correlation with multimodal imaging. Graefes Arch Clin Exp Ophthalmol. 2022;260(7):2231–2237. DOI: 10.1007/s00417-021-05537-x</mixed-citation><mixed-citation xml:lang="en">Maltsev DS, Kulikov AN, Burnasheva MA, Chhablani J. En face optical coherence tomography transillumination for evaluation of retinal pigment epithelium alteration in central serous chorioretinopathy: correlation with multimodal imaging. Graefes Arch Clin Exp Ophthalmol. 2022;260(7):2231–2237. DOI: 10.1007/s00417-021-05537-x</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Kulikov AN, Maltsev DS, Burnasheva MA, Chhablani J. Dark Field Scanning Laser Ophthalmoscopy for Prediction of Central Serous Chorioretinopathy Responsiveness to Laser Therapy. J Curr Ophthalmol. 2021;33(4):461–467. DOI: 10.4103/joco.joco_257_21</mixed-citation><mixed-citation xml:lang="en">Kulikov AN, Maltsev DS, Burnasheva MA, Chhablani J. Dark Field Scanning Laser Ophthalmoscopy for Prediction of Central Serous Chorioretinopathy Responsiveness to Laser Therapy. J Curr Ophthalmol. 2021;33(4):461–467. DOI: 10.4103/joco.joco_257_21</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Fukushima A, Maruko I, Chujo K, Hasegawa T, Arakawa H, Iida T. Characteristics of treatment naïve quiescent choroidal neovascularization detected by optical coherence tomography angiography in patients with age related macular degeneration. Graefes Arch Clin Exp Ophthalmol. 2021;259(9):2671–2677. DOI: 10.1007/s00417-021-05127-x</mixed-citation><mixed-citation xml:lang="en">Fukushima A, Maruko I, Chujo K, Hasegawa T, Arakawa H, Iida T. Characteristics of treatment naïve quiescent choroidal neovascularization detected by optical coherence tomography angiography in patients with age related macular degeneration. Graefes Arch Clin Exp Ophthalmol. 2021;259(9):2671–2677. DOI: 10.1007/s00417-021-05127-x</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Serra R, Coscas F, Boulet JF. Predictive activation biomarkers of treatment-naive asymptomatic choroidal neovascularization in age-related macular degeneration. Retina Phila Pa. 2020;40(7):1224–1233. DOI: 10.1097/IAE.0000000000002604</mixed-citation><mixed-citation xml:lang="en">Serra R, Coscas F, Boulet JF. Predictive activation biomarkers of treatment-naive asymptomatic choroidal neovascularization in age-related macular degeneration. Retina Phila Pa. 2020;40(7):1224–1233. DOI: 10.1097/IAE.0000000000002604</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">von der Emde L, Thiele S, Pfau M. Assessment of Exudative Activity of Choroidal Neovascularization in Age-Related Macular Degeneration by OCT Angiography. Ophthalmologica. 2020;243(2):120–128. DOI: 10.1159/000503609</mixed-citation><mixed-citation xml:lang="en">von der Emde L, Thiele S, Pfau M. Assessment of Exudative Activity of Choroidal Neovascularization in Age-Related Macular Degeneration by OCT Angiography. Ophthalmologica. 2020;243(2):120–128. DOI: 10.1159/000503609</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Al-Sheikh M, Iafe NA, Phasukkijwatana N, Sadda SR, Sarraf D. Biomarkers of neovascular activity in age related macular degeneration using optical coherence tomography angiography. Retina Phila Pa. 2018;38(2):220–230. DOI: 10.1097/IAE.0000000000001628</mixed-citation><mixed-citation xml:lang="en">Al-Sheikh M, Iafe NA, Phasukkijwatana N, Sadda SR, Sarraf D. Biomarkers of neovascular activity in age related macular degeneration using optical coherence tomography angiography. Retina Phila Pa. 2018;38(2):220–230. DOI: 10.1097/IAE.0000000000001628</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Christenbury JG, Phasukkijwatana N, Gilani F, Freund KB, Sadda S, Sarraf D. Progression of macular atrophy in eyes with type 1 neovascularization and age-related macular degeneration receiving long term intravitreal anti-vascular endothelial growth factor therapy: An Optical Coherence Tomographic Angiography Analysis. Retina Phila Pa. 2018;38(7):1276–1288. DOI: 10.1097/IAE.0000000000001766</mixed-citation><mixed-citation xml:lang="en">Christenbury JG, Phasukkijwatana N, Gilani F, Freund KB, Sadda S, Sarraf D. Progression of macular atrophy in eyes with type 1 neovascularization and age-related macular degeneration receiving long term intravitreal anti-vascular endothelial growth factor therapy: An Optical Coherence Tomographic Angiography Analysis. Retina Phila Pa. 2018;38(7):1276–1288. DOI: 10.1097/IAE.0000000000001766</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
